Being a non-malignant haematologist, I have always hated the term non-malignant! Even though I’m told by those who know me that I am not malignant, I don’t think anything (or anyone) should be defined by what it isn’t. I know I’m not alone in this...
10 months ago
Blinatumomab significantly improves survival among patients with B-cell precursor acute lymphoblastic leukaemia, researchers have reported.
Reporting in the New England Journal of Medicine, the E1910 trial added the immunotherapy blinatumomab to c...
10 months ago
